Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 10c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.29), $0.10 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $3.59 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Tech eyes recovery after selloff, Micron to report results - What’s moving markets
• H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)